Report copyright - 203341Orig1s000 - Food and Drug AdministrationBOSULIF (bosutinib) Tablets are immediate-release tablets supplied in two strengths (100 and 500 mg). BOSULIF is indicated for the treatment
Please pass captcha verification before submit form